HBV mutations in EnhII/BCP/PC region contribute to the prognosis of hepatocellular carcinoma.
Zijun GeTing TianLijuan MengCi SongChengxiao YuXin XuJibin LiuJuncheng DaiZhi-Bin HuPublished in: Cancer medicine (2019)
These findings indicated that, in Chinese population, nt1753 in EnhII/BCP/PC region might be a novel marker for HCC prognosis.
Keyphrases